Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose.
| Author | |
|---|---|
| Abstract |
:
Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap) vaccine is recommended in many countries for boosting immunity in adolescents and adults. Although immunity to these antigens wanes with time, currently available Tdap products are not labeled for repeat administration in the United States. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of the Pediatric Infectious Diseases Society
|
| Date Published |
:
2018
|
| ISSN Number |
:
2048-7193
|
| URL |
:
https://academic.oup.com/jpids/article-lookup/doi/10.1093/jpids/pix113
|
| DOI |
:
10.1093/jpids/pix113
|
| Short Title |
:
J Pediatric Infect Dis Soc
|
| Download citation |
